ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,061Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 198

$484K Total Retail Price of All Prescriptions

Rank: 65 out of 198

388 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 388 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 11,473 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 641 633 1 2
LEVOTHYROXINE SODIUM 527 506 2 1
FUROSEMIDE 525 498 3 5
AMLODIPINE BESYLATE 491 491 4 4
OMEPRAZOLE 472 447 5 3
LISINOPRIL 420 406 6 6
METOPROLOL TARTRATE 305 294 7 10
WARFARIN SODIUM 266 266 8 7
CITALOPRAM HBR 259 242 9 20
ATORVASTATIN CALCIUM 245 243 10 12
METOPROLOL SUCCINATE 234 224 11 11
POTASSIUM CHLORIDE 227 215 12 9
TRAMADOL HCL 221 199 13 15
METFORMIN HCL 210 194 14 13
MELOXICAM 194 194 15 30
GABAPENTIN 186 183 16 14
ATENOLOL 170 165 17 17
HYDROCODONE-ACETAMINOPHEN 153 148 S3 18 8
ALLOPURINOL 149 149 19 23
PRAVASTATIN SODIUM 137 133 20 19
GLIPIZIDE 136 130 21 62
ZOLPIDEM TARTRATE 135 117 22 22
CELEBREX 131 119 23 59
BUSPIRONE HCL 128 126 24 132
LANTUS 120 85 25 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 114 114 26 38
DONEPEZIL HCL 103 103 27 28
ALENDRONATE SODIUM 100 98 28 21
GLYBURIDE-METFORMIN HCL 92 92 R 29 173
AMIODARONE HCL 86 86 30 119
CARBIDOPA-LEVODOPA 80 80 31 71
GLIMEPIRIDE 79 79 32 35
GEMFIBROZIL 78 73 33 110
CRESTOR 78 78 33 26
TAMSULOSIN HCL 76 76 35 27
CLOPIDOGREL 74 74 36 42
CARVEDILOL 74 74 36 24
ALBUTEROL SULFATE 71 71 38 113
PREDNISONE 70 70 39 29
TRIAMTERENE-HYDROCHLOROTHIAZID 69 69 40 142
TORSEMIDE 67 67 41 75
ESCITALOPRAM OXALATE 66 66 42 53
PLAVIX 65 65 43 66
NEXIUM 65 65 43 40
ISOSORBIDE MONONITRATE ER 63 63 45 60
PANTOPRAZOLE SODIUM 61 60 46 31
AZITHROMYCIN 60 57 47 56
BYSTOLIC 60 60 47 58
GLYBURIDE 59 59 R 49 103
HUMALOG 58 42 50 128
CLOTRIMAZOLE-BETAMETHASONE 56 56 51 205
AMITRIPTYLINE HCL 56 56 R 51 69
CEPHALEXIN 53 47 53 108
HYDROCHLOROTHIAZIDE 53 53 53 16
ACTOS 52 52 55 115
DIGOXIN 51 51 56 43
TRIAMTERENE-HCTZ 51 51 56 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.